Han et al. reported that high levels of M2 macrophages and naïve B cells correlate with poor survival, whereas CD8 T cells and activated CD4 memory T cells correlate with better outcomes in NSCLC [170]. This evidence concerns the gene CD4 and non-small cell lung carcinoma.